Orticumab (MLDL1278A) is a monoclonal antibody designed to target and inhibit oxidized or malondialdehyde-modified low-density lipoprotein (oxLDL). This antibody plays a crucial role in modulating autoimmune responses against oxLDL, which is implicated in the pathogenesis of atherosclerosis. Studies have demonstrated that Orticumab effectively improves atherosclerotic conditions in animal models. Additionally, it holds potential for research applications in exploring therapeutic avenues for psoriasis improvement. This antibody's specificity for oxLDL makes it a valuable tool in cardiovascular and autoimmune disease research.
Orticumab (MLDL1278A) is a monoclonal antibody designed to target and inhibit oxidized or malondialdehyde-modified low-density lipoprotein (oxLDL). This antibody plays a crucial role in modulating autoimmune responses against oxLDL, which is implicated in the pathogenesis of atherosclerosis. Studies have demonstrated that Orticumab effectively improves atherosclerotic conditions in animal models. Additionally, it holds potential for research applications in exploring therapeutic avenues for psoriasis improvement. This antibody's specificity for oxLDL makes it a valuable tool in cardiovascular and autoimmune disease research.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
